Real World Evidence

Real-World Data and the COVID-19 Pandemic

Real-World Data and the COVID-19 Pandemic Event Time: 12:00 – 1:00 p.m. ET Event Location: Virtual, Zoom Moderator: Gillian Sanders Schmidler, PhD, Deputy Director, Duke-Margolis Center for Health Policy and […]

Read more

Evaluating the Quality of Real-World Evidence

Evaluating the Quality of Real-World Evidence Event Time: 12:00 – 12:45 p.m. ET Event Location: Virtual, Zoom Moderator: Elisabeth Oehrlein, PhD, MS, Assistant Vice President, Research and Programs, National Health […]

Read more

Sources of RWD: An Introduction to Patient Registries

Sources of RWD: An Introduction to Patient Registries Moderator: Elisabeth Oehrlein, PhD, MS, Senior Director, Research & Programs, National Health Council Robert McBurney, PhD, Chief Research Officer, Accelerated Cure Project for Multiple Sclerosis […]

Read more

Sources of RWD: An Introduction to “Big Data”

This webinar will introduce big data, an umbrella term used to describe some types of real-world data. Big data can come from health care visits, including information from electronic health records and insurance claims, and it also can come from “non-traditional” sources such as social media and wearable devices.

Read more

Real-World Data and Real-World Evidence 101

This webinar will introduce essential terminology related to real-world data (RWD) and real-world evidence (RWE). We will discuss how RWE complements evidence from traditional randomized clinical trials and highlight case examples.

Read more

PCORI Real World Evidence (RWE) Advisory Board

PCORI Real World Evidence (RWE) Advisory Board Members Vanessa Boulanger, MSc, Director of Research Programs, National Organization for Rare Disorders Susan dosReis, PhD, Professor and Vice Chair for Research, Pharmaceutical […]

Read more